Rakovina Therapeutics Inc. (TSXV:RKV)
Canada · Delayed Price · Currency is CAD 0.1400
+0.0100 (7.69%)
Jun 26, 2026, 10:44 AM EST
Rakovina Therapeutics Market Cap
Rakovina Therapeutics has a market cap or net worth of CAD 3.42 million as of June 26, 2026. Its market cap has decreased by -59.32% in one year.
Market Cap
3.42M
Enterprise Value
5.84M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.14
Market Cap Chart
Since April 1, 2021, Rakovina Therapeutics's market cap has decreased from 14.88M to 3.42M, a decrease of -77.02%. That is a compound annual growth rate of -24.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 3.42M | 61.62% |
| Dec 31, 2025 | 2.11M | -92.08% |
| Dec 31, 2024 | 26.69M | 348.09% |
| Dec 29, 2023 | 5.96M | -52.61% |
| Dec 29, 2022 | 12.57M | -18.16% |
| Dec 31, 2021 | 15.36M | 3.25% |
| Apr 1, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kane Biotech | 6.15M |
| Restart Life Sciences | 5.50M |
| Innovotech | 5.44M |
| Aptose Biosciences | 5.44M |
| MYND Life Sciences | 5.22M |
| Quest PharmaTech | 5.07M |
| PharmaTher Holdings | 4.55M |
| BioVaxys Technology | 3.09M |